MHRA Drug Safety Update: February 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 7 February 2024) has been published and includes articles on:

  • Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine
  • Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)
  • Letters and medicine recalls sent to healthcare professionals in January 2024.

To see the latest MHRA Drug Safety Updates in full, visit the website.